(Press-News.org) Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma – a malignant form of cancer in children – that focuses on the so-called MYCN protein. A specific chemical molecule helps to break down MYCN, which either kills the cancer cell or makes it mature into a harmless neuron. The discovery, which is published in the scientific journal PNAS, raises hopes for new and more effective treatments in the future.
Neuroblastoma is the third most common form of cancer in children. It usually develops before the age of two and affects around two dozen children per year in Sweden and around 800 in the US. The tumours are normally located in the peripheral nervous system, but in very young infants they can sometimes spread over the entire body. Current therapies are tough and have serious side effects, and for many of the patients the prognosis is poor. In its most aggressive form only a minority survive, which makes finding alternative treatments particularly urgent.
In the case of neuroblastoma, extra copies of the gene that encodes the MYCN protein are normally found in the cancer cell. This in turn is a clear indication of a poor prognosis, as it has long been known that the incorrect activation of the MYCN and similar MYC genes causes cancer. The strategy of the research group for defeating the disease was therefore to identify substances that prevent MYC-triggered cell division or that kill cancer cells in an MYC-specific manner.
"We have found that a small chemical molecule, that is known from previous studies to inhibit the activity of the c-MYC-protein, also inhibits the activity of MYCN," says Principal Investigator Marie Arsenian Henriksson, Professor of molecular tumour biology at Karolinska Institutet. "The substance disrupts the binding between MYCN and another protein called Max, which results in the degradation of MYCN and subsequently either to cell death in neuroblastoma cells with extra copies of the MYCN gene, or to their development into neurons, at which point their malignity disappears. Small chemical molecules that knock out MYCN are therefore a possible therapy option for children with neuroblastoma as well as for other MYC-driven tumours."
The molecule used by the researchers is no drug candidate; instead the finding is to be seen as a model that can inspire future cancer therapies. However, the researchers did find that the survival rate increased when they applied test treatments on mice with neuroblastoma. The study also led to a new discovery on what happens inside the cancer cell, where the treatment caused an accumulation of fat droplets, suggesting that the MYC proteins affect tumour cell metabolism and the normal breakdown of fatty acids.
"This is an original finding," says Professor Arsenian Henriksson. "It has not previously been observed that the inhibition of MYC affects tumour cells in this way. This does not only open new avenues for novel therapies for certain forms of cancer, but may also have implications for metabolic diseases, such as diabetes."
INFORMATION:
The study was financed with grants from several bodies, including the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, Karolinska Institutet, and the Hedlund Foundation.
Publication: 'MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells', Hanna Zirath, Anna Frenzel, Ganna Oliynyk, Lova Segerström, Ulrica K. Westermark, Karin Larsson, Matilda Munksgaard Person, Kjell Hultenby, Janne Lehtiö, Christer Einvik, Sven Påhlman, Per Kogner, Per-Johan Jakobsson, and Marie Arsenian Henriksson, PNAS online 3-7 June 2013. EMBARGOED until 3 June 2013 at 3 pm US Eastern Time / 21:00 CET / 20:00 UK time.
Visit the journal website at: http://www.pnas.org
For further information, please contact:
Professor Marie Arsenian Henriksson
Department of microbiology, Tumour and Cell Biology, Karolinska Institutet
Tel: +46 (0)8-524 862 05
E-mail: marie.henriksson@ki.se
Contact the Press Office at Karolinska Institutet and download images: ki.se/pressroom
Karolinska Institutet – a medical university: ki.se/English
New strategy for defeating neuroblastoma
2013-06-04
ELSE PRESS RELEASES FROM THIS DATE:
Expanding Medicaid is best financial option for states, study finds
2013-06-04
States that choose not to expand Medicaid under federal health care reform will leave millions of their residents without health insurance and increase spending, at least in the short term, on the cost of treating uninsured residents, according to a new RAND Corporation study.
If 14 states decide not to expand Medicaid under the Affordable Care Act as intended by their governors, those state governments collectively will spend $1 billion more on uncompensated care in 2016 than they would if Medicaid is expanded.
In addition, those 14 state governments would forego ...
Early-life risk factors account for racial and ethnic disparities in childhood obesity
2013-06-04
Early-life risk factors -- most of which could be changed -- appear to explain the recognized racial and ethnic disparities in the incidence of childhood overweight and obesity. In a report being published online in JAMA Pediatrics, a team of researchers report a prospective study finding that increased prevalence of obesity and overweight among black and Hispanic 7-year-olds could largely be explained by risk factors such as rapid infant weight gain, early introduction of solid foods and a lack of exclusive breast feeding.
"We know that, already by the age of 2, black ...
New biomolecular archaeological evidence points to the beginnings of viniculture in France
2013-06-04
PHILADELPHIA, PA June 2013—France is renowned the world over as a leader in the crafts of viticulture and winemaking—but the beginnings of French viniculture have been largely unknown, until now.
Imported ancient Etruscan amphoras and a limestone press platform, discovered at the ancient port site of Lattara in southern France, have provided the earliest known biomolecular archaeological evidence of grape wine and winemaking—and point to the beginnings of a Celtic or Gallic vinicultural industry in France circa 500-400 BCE. Details of the discovery are published as "The ...
USC report: Law dramatically reduced hospital prices for the uninsured
2013-06-04
To comply with a statewide "fair pricing" law, hospitals throughout California have significantly lowered prices to uninsured patients, with nearly all even going beyond the state mandate and offering free care to those below the poverty line.
The surprising success of the legislation represents the beginnings of a safety net not in place for other states.
Some 6.8 million people in California lack health insurance, often relying on hospital emergency departments for healthcare. Based on hospital billing plans, those visits can rack up huge bills that the uninsured ...
Turning point for early human diets occurred 3.5 million years ago
2013-06-04
SAN FRANCISCO (June 3, 2013) — The old saying "You are what you eat" takes on new significance in the most comprehensive analysis to date of early human teeth from Africa. Prior to about 3.5 million years ago, early humans dined almost exclusively on leaves and fruits from trees, shrubs, and herbs—similar to modern-day gorillas and chimpanzees. However, about 3.5 million years ago, early human species like Australopithecus afarensis and Kenyanthropus platyops began to also nosh on grasses, sedges, and succulents—or on animals that ate those plants. Evidence of this ...
New kind of antibiotic may be more effective at fighting tuberculosis, anthrax, and other diseases
2013-06-04
Diseases such as tuberculosis, anthrax, and shigellosis -- a severe food-borne illness -- eventually could be treated with an entirely new and more-effective kind of antibiotic, thanks to a team of scientists led by Kenneth Keiler, an associate professor of biochemistry and molecular biology at Penn State University. In a research paper that will be published in the journal Proceedings of the National Academy of Sciences during the week beginning 3 June 2013, the team describes 46 previously untested molecules that target and disrupt an important step in the process of ...
Diet likely changed game for some hominids 3.5 million years ago, says CU-Boulder study
2013-06-04
A new look at the diets of ancient African hominids shows a "game changer" occurred about 3.5 million years ago when some members added grasses or sedges to their menus, according to a new study led by the University of Colorado Boulder.
High-tech tests on tooth enamel by researchers indicate that prior to about 4 million years ago, Africa's hominids were eating essentially chimpanzee style, likely dining on fruits and some leaves, said CU-Boulder anthropology Professor Matt Sponheimer, lead study author. Despite the fact that grasses and sedges were readily available ...
For some men, it's 'T' time -- test or no test
2013-06-04
GALVESTON, Texas — Prescriptions for testosterone therapy have increased significantly during the last 10 years, according to a study in the current issue of JAMA Internal Medicine conducted by researchers at the University of Texas Medical Branch.
About 50 percent of the men in the study who had received testosterone therapy had been diagnosed as having hypogonadism, a condition where a man is unable to produce the normal levels of testosterone.
But the study also found that, among new users of a prescription androgen product, about 25 percent did not have their testosterone ...
Musculoskeletal conditions, injuries may be associated with statin use
2013-06-04
Using cholesterol-lowering statins may be associated with musculoskeletal conditions, arthropathies (joint diseases) and injuries, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
While statins effectively lower cardiovascular illnesses and death, the full spectrum of statin musculoskeletal adverse events (AEs) is unknown. Statin-associated musculoskeletal AEs include a wide variety of clinical presentations, including muscle weakness, muscle cramps and tendinous (tendon) diseases, the authors write in the study background.
Ishak ...
Vegetarian diets associated with lower risk of death
2013-06-04
Vegetarian diets are associated with reduced death rates in a study of more than 70,000 Seventh-day Adventists with more favorable results for men than women, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
The possible relationship between diet and mortality is an important area of study. Vegetarian diets have been associated with reductions in risk for several chronic diseases, including hypertension, metabolic syndrome, diabetes mellitus and ischemic heart disease (IHD), according to the study background.
Michael ...